Sclerosis multiplex (SM): vizsgálatok itt: Írország
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Where
- Dublin
- Életkor
- 18 év to 65 év
- People
- 1275 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07225504 - No phaseTaking peoplePregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- Where
- Dublin
- People
- 908 worldwide
- Run by
- Biogen
See details and how to joinNCT05658497 - 3. fázisTaking peopleA clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
- Where
- Dublin 24, Dublin 8, Dublin 9
- Életkor
- 18 év and over
- People
- 677 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521546-23-00 · EU 2025-521546-23-00 - 2. fázisNot yet taking people in ÍrországImplementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis
- Where
- Dublin
- Életkor
- 18 év and over
- People
- 94 worldwide
- Run by
- Danish Multiple Sclerosis Hospitals
See details and how to joinNCT07310914